| 68 |
[논문] Clinical Usefulness of 18F-FC119S Positron-Emission Tomography as an Auxiliary Diagnostic Method for Dementia: An Open-Label, Single-Dose, Evaluator-Blind Clinic…
|
관리자 |
작성일22.06.24 |
조회1,166 |
| 67 |
[논문] 18 F-labeled 1,2,3-triazole-linked Glu-urea-Lys-based PSMA ligands have good pharmacokinetic properties for positron emission tomography imaging of prostate canc
|
관리자 |
작성일22.06.24 |
조회1,181 |
| 66 |
[논문] Early Detection of Aβ Deposition in the 5xFAD Mouse by Amyloid PET.
|
관리자 |
작성일22.06.24 |
조회1,188 |
| 65 |
[논문] Alternative synthesis for the preparation of 16α-[(18) F]fluoroestradiol.
|
관리자 |
작성일22.06.24 |
조회1,148 |
| 64 |
[논문] A microdose clinical trial to evaluate [ 18 F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer
|
관리자 |
작성일22.06.24 |
조회1,186 |
| 63 |
[논문] A Phase 0 Microdosing PET/CT Study Using O-[18F]Fluoromethyl-d-Tyrosine in Normal Human Brain and Brain Tumor
|
관리자 |
작성일22.06.24 |
조회1,207 |
| 62 |
[논문] Improving Theranostic Gallium-68/Lutetium-177-Labeled PSMA Inhibitors with an Albumin Binder for Prostate Cancer
|
관리자 |
작성일22.06.24 |
조회1,213 |
| 61 |
퓨쳐켐, 美학회서 방사선치료제 'FC705' 연구 결과 3건 발표
|
관리자 |
작성일22.06.16 |
조회1,286 |
| 60 |
퓨쳐켐, 전립선암 치료제 'FC705' 국내 식약처 치료목적 사용 승인
|
관리자 |
작성일22.06.14 |
조회1,284 |
| 59 |
퓨쳐켐, FC705 美 FDA 임상 1/2a상 IND 승인…글로벌 임상 돌입
|
관리자 |
작성일22.05.27 |
조회1,328 |
